BridgeMD
New treatment option for ADHD
Official title ADHD&me: Targeting Self-esteem in Youth With ADHD
ClinicalTrials.gov ID: NCT07504107
What this study is testing
- What it's testing
- The goal of this clinical trial is to learn whether the ADHD\&me (ADHD\&ik) intervention can improve self-esteem in youth aged 16-25 years with Attention Deficit Hyperactivity Disorder (ADHD). The ADHD\&me program is a cognitive behavioral therapy (CBT)-based intervention designed to help people with ADHD to develop a more positive view of themselves in their transition to adulthood.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 16 to 25
You may be able to join if
- 16-25 years old.
- Official ADHD diagnosis, that is confirmed by research team using the clinical interview MINI-S.
- Low self-esteem, determined through a structured and multi-step procedure to minimize subjectivity:
- Referral by clinician. Clinicians from participating institutions identify potential participants. To ensure a uniform understanding of the study...
- Telephone screening. Two items from the Rosenberg Self-Esteem Scale (RSES; Rosenberg, 1965) are administered ("At times I think I am no good at all"...
You likely can't join if
- Concurrent psychopathology that requires immediate attention (e.g., severe depression, suicidal thoughts/risk of suicide (as determined by the...
- Undergoing any concurrent psychological treatment during the study, including any form of therapy for ADHD (e.g., CBT for planning skills)...
- Low self-esteem that directly stems from a traumatic experience, which would indicate the need for trauma-specific treatment. This will be determined...
- IQ \< 80 assessed with two WAIS-IV subscales (Wechsler, 2008): Vocabulary and Block Design.
- Severe substance use (as determined by the referring therapist and/or research team).
- Confirmed Autism Spectrum Disorder (ASD) diagnosis. This also applies when the referring therapist indicates that an ASD diagnosis is very likely...
See the full eligibility criteria
- 16-25 years old.
- Official ADHD diagnosis, that is confirmed by research team using the clinical interview MINI-S.
- Low self-esteem, determined through a structured and multi-step procedure to minimize subjectivity:
- Referral by clinician. Clinicians from participating institutions identify potential participants. To ensure a uniform understanding of the study population and , all clinicians receive specific training. The...
- Telephone screening. Two items from the Rosenberg Self-Esteem Scale (RSES; Rosenberg, 1965) are administered ("At times I think I am no good at all" and "All in all, I am inclined to think I am a failure"). A score of 3...
- Baseline confirmation. During the baseline measurement, the full Rosenberg Self-Esteem Scale is administered. A cutoff score of \< 15 is used as an objective reference point. This score is combined with a standardized...
- Pharmacological treatment for ADHD is allowed, but medication dose should be stabilized for a minimum of 4 weeks at baseline measurement (T0). Although changes in ADHD medication during the study are not preferred, they...
- Concurrent psychopathology that requires immediate attention (e.g., severe depression, suicidal thoughts/risk of suicide (as determined by the referring therapist and/or research team). Other comorbidity is allowed.
- Undergoing any concurrent psychological treatment during the study, including any form of therapy for ADHD (e.g., CBT for planning skills). Psychoeducation completed prior to the study entry is allowed, but not during...
- Low self-esteem that directly stems from a traumatic experience, which would indicate the need for trauma-specific treatment. This will be determined by the referring therapist. If someone in addition suffers from low...
- IQ \< 80 assessed with two WAIS-IV subscales (Wechsler, 2008): Vocabulary and Block Design.
- Severe substance use (as determined by the referring therapist and/or research team).
- Confirmed Autism Spectrum Disorder (ASD) diagnosis. This also applies when the referring therapist indicates that an ASD diagnosis is very likely, even if it has not yet been established. Since ASD diagnostic procedures...
The study team makes the final eligibility decision.
Where it's taking place
- Haarlem, Netherlands
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 16 years to 25 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Haarlem, Netherlands. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.